ADVERTISEMENT
News
ActiGraft - RedDress
09/10/2024
https://www.globenewswire.com/en/news-release/2024/09/03/2939626/0/en/RedDress-Announces-Randomized-Controlled-Trial-Results-Showing-Significant-Benefits-of-ActiGraft-Pro-for-Diabetic-Foot-Ulcers.html
RedDress announced that ActiGraft Pro demonstrated exceptional efficacy in facilitating healing for chronic neuropathic DFUs. ActiGraft Pro showed significant superiority, with 2.73 greater odds of reaching complete wound closure by week 12 compared to the control (SoC).